| Bid Price | 5.70p | High Price | 6.00p |
|---|
| Ask Price | 6.00p | Low Price | 5.70p |
|---|
| Open Price | 5.85p | Spread | 5.00% |
|---|
| Prev Close | 5.85p | Volume | 45,512 |
|---|
Renalytix PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Sep 12, 2025 | 5.85 | 6.00 | 5.70 | 5.85 | 45,512 |
| Sep 11, 2025 | 5.85 | 6.00 | 5.72 | 5.85 | 750,801 |
| Sep 10, 2025 | 5.85 | 5.78 | 5.71 | 5.85 | 34,268 |
| Sep 9, 2025 | 5.85 | 5.70 | 5.70 | 5.85 | 35,701 |
| Sep 8, 2025 | 5.85 | 6.00 | 5.70 | 5.85 | 116,808 |
Renalytix PLC Information
| Name | Renalytix PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00BYWL4Y04 | Epic | RENX |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASX1 |
|---|
| Industry | Health Information Services | Sector | Healthcare |
|---|
| EMS | 20,000 | Trading Status | Closed |
|---|
| Shares in Issue | 331.21 m | Prev Close | 5.85p |
|---|
| PE Ratio | | Market Cap | £19.38 m |
|---|
| Div Yield | 0 | Div per Share | $NaN |
|---|
| EPS | -$0.05 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | n/a | DPS Growth (%) | 0 |
|---|
| Current Ratio | 2.429967 | Quick Ratio | 2.201086 |
|---|
Renalytix PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 20/12/24 | BUY | Fergus Fleming | ED | 25,000 @ £0.10 | £2,438.00 |
| 11/12/24 | BUY | Julian Baines | RES | 23,000 @ £0.09 | £1,955.00 |
| 11/12/24 | BUY | James McCullough | CEO | 25,000 @ £0.09 | £2,125.00 |
| 11/12/24 | BUY | Christopher Mills | NED | 48,601 @ £0.07 | £3,402.00 |
| 06/12/24 | BUY | James McCullough | CEO | 53,300 @ £0.08 | £3,998.00 |
| 04/12/24 | BUY | Julian Baines | RES | 23,989 @ £0.07 | £1,739.00 |
| 11/10/24 | BUY | Christopher Mills | NED | 500,000 @ £0.09 | £45,000.00 |
| 11/10/24 | SELL | Christopher Mills | NED | 83,696 @ £0.08 | £6,696.00 |
| 09/10/24 | PLAC | Christopher Mills | NED | 500,000 @ £0.09 | £45,000.00 |
| 09/10/24 | PLAC | James McCullough | CEO | 417,710 @ £0.09 | £37,594.00 |
Renalytix PLC News
